NeoGenomics, Inc. Deferred Tax Assets, Tax Credit Carryforwards
NeoGenomics, Inc. (NEO) had Deferred Tax Assets, Tax Credit Carryforwards of $15.31 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxCreditCarryforwards · last filed 2026-02-17
- 2025-12-31: Deferred Tax Assets, Tax Credit Carryforwards $15.31M.
- 2024-12-31: Deferred Tax Assets, Tax Credit Carryforwards $11.49M.
- 2023-12-31: Deferred Tax Assets, Tax Credit Carryforwards $11.08M.
- 2022-12-31: Deferred Tax Assets, Tax Credit Carryforwards $8.98M.
| Period end | Deferred Tax Assets, Tax Credit Carryforwards |
|---|---|
| 2025-12-31 | $15.31M 10-K · filed 2026-02-17 |
| 2024-12-31 | $11.49M 10-K · filed 2026-02-17 |
| 2023-12-31 | $11.08M 10-K · filed 2025-02-18 |
| 2022-12-31 | $8.98M 10-K · filed 2024-02-20 |
| 2021-12-31 | $6.60M 10-K · filed 2023-02-24 |
| 2020-12-31 | $4.58M 10-K · filed 2022-02-25 |
| 2019-12-31 | $0.00 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |